Predicting Success in Regulatory Approval From Phase I Results

par Malik, Laeeq, Mejia, Alex, Parsons, Helen, Ehler, Benjamin, Mahalingam, Devalingam, Brenner, Andrew, Sarantopoulos, John, Weitman, Steven
Publié dans Cancer Chemother Pharmacol (2014)

Clinical outcomes and survival of advanced renal cancer patients in Phase I clinical trials

par Malik, Laeeq, Parsons, Helen, Mahalingam, Devalingam, Ehler, Benjamin, Goros, Martin, Mejia, Alex, Brenner, Andrew, Sarantopoulos, John
Publié dans Clin Genitourin Cancer (2014)

Lineage of origin in rhabdomyosarcoma informs pharmacological response

par Abraham, Jinu, Nuñez-Álvarez, Yaiza, Hettmer, Simone, Carrió, Elvira, Chen, Hung-I Harry, Nishijo, Koichi, Huang, Elaine T., Prajapati, Suresh I., Walker, Robert L., Davis, Sean, Rebeles, Jennifer, Wiebush, Hunter, McCleish, Amanda T., Hampton, Sheila T., Bjornson, Christopher R.R., Brack, Andrew S., Wagers, Amy J., Rando, Thomas A., Capecchi, Mario R., Marini, Frank C., Ehler, Benjamin R., Zarzabal, Lee Ann, Goros, Martin W., Michalek, Joel E., Meltzer, Paul S., Langenau, David M., LeGallo, Robin D., Mansoor, Atiya, Chen, Yidong, Suelves, Mònica, Rubin, Brian P., Keller, Charles
Publié 2014